Citigroup upgrades Bristol-Myers Squibb Co (NYSE: BMY) from Hold to Buy.

Citigroup analyst says, "In light of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE